HM Hospitales and Roche partner to collaborate on research, training, and precision medicine
HM Hospitales y Roche se alían para colaborar en investigación, formación y medicina de precisión
Intel ID : 387232
Relevant Documents
| Press Release | 22 Feb 2024 | HM_Hospitales_Nota_de_Prensa_2024.pdf | ES |
|
| Intel ID | 387232 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - HM Hospitales
(31 Dec 2023) |
Revenue: EUR 374,68m EBITDA: EUR 25,87m Net Debt: EUR 58,73m |
||
| Date |
 |
||
| Country |  |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Subsector (TTRSC) |
30.03.08 Hospitals (Primary) 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.03.08 Hospitals 30 Healthcare / 30.03 Healthcare Facilities & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.